January 14, 2025 01:43 PM EST
Manufacturing

Charles Riv­er dis­ap­points in­vestors with damp out­look for 2025

Anna Brown

News Reporter

Charles Riv­er Lab­o­ra­to­ries is pre­dict­ing 2025 to be as tough as last year for CD­MOs as phar­ma cus­tomers con­tin­ue to cut costs with man­u­fac­tur­ers. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Eli Lil­ly miss­es 2024 rev­enue ex­pec­ta­tions, stock dips 7%

#JPM25 live blog day 2: Nvidia makes it fun; The year's 10th megaround

Lykos up­heaval con­tin­ues with four new board ex­its amid hunt for cash

HHS in­spec­tor gen­er­al rais­es con­cerns over three FDA ac­cel­er­at­ed ap­provals

FTC goes af­ter phar­ma mid­dle­men's price hikes on 'spe­cial­ty' drugs

How a start­up is reimag­in­ing health in­sur­ance, as em­ploy­ers search for new op­tions

A service from the Financial Times